The US Food and Drug Administration expects questions about problem products and companies in the dietary supplement sector could be answered not only from industry stakeholders’ input but also through congressional clarification.
“Clarification of statutory language is often helpful
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?